Angelus Venture Fund

Angelus Venture Fund appears to be a private venture investment vehicle rather than an operating drug-development company. Publicly available evidence links it to healthcare and medtech investing, including participation as a lead investor in Signifier Medical Technologies' 2021 Series D financing alongside Segulah Medical Acceleration and Pioneer Healthcare Partners. The entity is most commonly referenced as "Angelus Venture Fund" or "Angelus Venture Fund I L.P." in transaction coverage and private-markets databases. There is no clear public evidence that it develops therapeutics, runs a clinical pipeline, or operates proprietary healthcare products directly. It is better characterized as a specialist investment fund with exposure to healthcare opportunities.